Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications cardiovascular risk factors disease among non european immigrants living catalonia
… RTI, our mission is our calling, and we are committed to living it every day, in our work and in our actions,” said …
… In 2024, 15 more drugs will be chosen for the program. European Health Technology Assessment Regulation The European Regulation on Health Technology Assessment (HTAR) is … moves along in its development, directives regarding rare disease therapies will be introduced in January 2028. And …
… Hematology Diabetes & Endocrine Disorders Dermatology Cardiovascular Manchester, United Kingdom PhD, Biotechnology … therapies), cardiovascular, respiratory, liver disease, arthritis, chronic pain, ophthalmology, and … Oncology, Value in Health and Therapeutics, and Clinical Risk Management . She was also co-chair of the ISPOR Good …
… how evidence ratings are assigned and identify key factors which influence ICER’s rating decisions. A total of …
… degree in Mathematics, where she studied topics such as disease modelling, competition, and optimization, amongst … defects, and the effects important modulatory factors have on this regenerative process. During her time at … oncology, rheumatology, and infectious diseases, among others. …
… function decline in autosomal dominant polycystic kidney disease (ADPKD) patients: assessment of real world … Influenza vaccine administration and effectiveness among patients with glomerular disease. Glenn DA, Pate V, Falk RJ, Walter EB, Denburg MR, …
… with our clients on projects to research rheumatology disease, rheumatology treatment, and complications and comorbidities of rheumatology disease. Our experience includes: Ankylosing spondylitis … diseases. Recent projects have included: Benefit-risk preference studies Decision-analytic models (cost …
… Elena Rivero Pharmacoepidemiology and Risk Management Gastroenterology Women's Health Dermatology … dermatology, gastroenterology, ophthalmology, and bone disease. She has led studies aimed at defining burden of disease, disease risk factors, and safety; supported sections of regulatory …
… effects is an important part of evaluating the benefit-risk balance of their products. However, primary efficacy … the long-term benefit of a treatment for kidney disease. Our client was developing a treatment that had been … on key influencing variables to control for differences among those variables Employed piecewise linear mixed models …
… Susana Perez-Gutthann Pharmacoepidemiology and Risk Management Rheumatology Barcelona, Spain MD, Medicine … of Epidemiology at Pharmacia, Novartis, and Ciba-Geigy; European Head of Epidemiology at Pfizer; and a postdoctoral … and research programs for safety, pharmacovigilance, risk management, development, real world evidence, and …